Literature DB >> 16305890

Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults.

Jürgen Hörer1, Julia Friebe, Christian Schreiber, Martin Kostolny, Julie Cleuziou, Klaus Holper, Rüdiger Lange.   

Abstract

BACKGROUND: Early correction is regarded as the treatment of choice for patients with tetralogy of Fallot or pulmonary atresia with ventricular septal defect. Nevertheless, some of these patients reach adulthood without early correction. This study sought to assess risk factors for operative mortality and determine the benefit of total correction in adolescent and adult patients.
METHODS: A retrospective analysis of 52 patients (>16 years at the time of corrective surgery) for tetralogy of Fallot (n = 42) or pulmonary atresia with ventricular septal defect (n = 10) between 1974 and 2003 was performed.
RESULTS: Age at correction was 28.9 +/- 9.9 (16 to 57 years). There were 8 early deaths (15.4%). Preoperative hemoglobin concentration (p = 0.002) and reconstruction of the right ventricular outflow tract with a patch (p = 0.002) were correlated with a significantly higher early mortality. Mean follow-up time was 12.3 +/- 10.4 years. Late deaths (n = 6; 11.5%) were cardiac-related in 2 of 6 cases. At follow-up, 28 patients (87.5%) were assigned to the New York Heart Association functional class I. Twenty-four patients led a normal life with full-time work, 6 patients were able to do part-time work, and only 2 patients experienced noticeable limitation on activities.
CONCLUSIONS: Repair of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in this patient group is associated with a high early mortality. Preoperative chronic cyanosis, expressed by elevated hemoglobin concentration, is predictive for early mortality. Because cyanosis has been shown to lead to multiorgan dysfunction, we conclude that preoperative multiorgan dysfunction may be the intrinsic risk factor for perioperative mortality. Surgical correction in this patient group should still be recommended because the functional status considerably improves.

Entities:  

Mesh:

Year:  2005        PMID: 16305890     DOI: 10.1016/j.athoracsur.2005.05.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Correction of tetralogy of Fallot in an adult using a stented bioprosthetic valved conduit.

Authors:  Keiko Kiyokawa; Kazutomo Goh; Nobuyuki Akasaka; Takayuki Kadohama; Kei Kazuno; Tadahiro Sasajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

2.  Survival to the age of 87 years in a woman with unoperated tetralogy of Fallot.

Authors:  Ty K Subhawong; Oleg Teytelboym
Journal:  J Radiol Case Rep       Date:  2009-08-01

3.  Surgical correction of tetralogy of Fallot in a 61-year-old patient.

Authors:  Hideki Tsubota; Tomohiro Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.